Overdrive: Guselkumab Efficacy for Psoriatic Arthritis
- Author
- HCPLive.com
- Published
- Fri 07 May 2021
- Episode Link
- https://audioboom.com/posts/8227990
We sat down with Philip J. Mease, MD, to discuss his study, “Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.”
Time stamps:
Time stamps:
0:35: Can you begin by giving me a general overview of the current treatment landscape for psoriatic arthritis?
2:12: Have you noticed any trends in treating psoriatic arthritis?
3:00: What are some of the challenges that rheumatologists face when trying to identify the most appropriate treatment option for their patients?
3:36: Why is discovering that guselkumab demonstrated efficacy that was comparable to other treatment options, such as subcutaneous TNF inhibitors so important?
5:17: Were there any limitations or strengths of the study that you would like to elaborate on?
8:21: Does your team plan on doing any further research on guselkumab for psoriatic arthritis?
9:29: Is there anything else that you'd like our audience to know about your research or psoriatic arthritis?
